Keeping Current CME artwork

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

Keeping Current CME

English - January 17, 2024 18:03 - 21 minutes - 29.7 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Multidisciplinary Team Best Practices to Improve Adherence for High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Cases From the Community
Next Episode: Updates in Breast Cancer From San Antonio 2023: Practice-Changing Data and Clinical Implications

Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies.

Credit available for this activity expires: 1/12/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999658?ecd=bdc_podcast_libsyn_mscpedu